张泽民院士团队长期深耕前沿单细胞测序与生物信息学技术，在肿瘤免疫微环境、多细胞互作机制领域取得一系列重大突破。作为生物信息与智慧医学专家，张泽民于 2023 ...

Over the past decade, the advent of immune checkpoint blockade (ICB) therapy has transformed cancer treatment. Unlike conventional cytotoxic and targeted therapies, immunotherapy leverages both the ...

Tumors do not communicate only with immune cells, blood vessels, and stromal tissue. A growing body of evidence suggests that ...

MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that a study co ...

Cancer cells can disarm the immune system not just by hiding from it, but by actively reprogramming nearby immune cells into a suppressed state. This previously unrecognized molecular interaction, ...

Metastatic colorectal cancer (mCRC) remains a leading cause of cancer-related mortality worldwide. While significant advances have been achieved with ...

Comparative Outcomes of Survival and Relapse After High-Dose-Rate Brachytherapy Versus External-Beam Radiotherapy Boost Following Concurrent Chemoradiation in Locally Advanced Cervical Cancer in ...

Lung cancer treatment and outcomes are profoundly influenced by the tumor microenvironment (TME), particularly in resectable ...

VIB-VUB researchers have developed a patient-relevant lung adenocarcinoma model combined with SEPARATE-Seq technology to ...